Home » Topics » Disease categories and therapies » Dermatologic

Dermatologic
RSS

Welichem begins IND-enabling toxicology studies for WBI-1001

April 22, 2009

Health Canada approves Photocure's Metvix in combination with Aktilite for AK and sBCC

April 22, 2009

Clinuvel provides update on afamelanotide

April 16, 2009

Ipsen provides update of FDA's review of its botulinum toxin type A product

April 14, 2009

Genentech voluntarily withdraws Raptiva from the U.S. market

April 9, 2009

GLYC-101 achieves accelerated wound closure based on interim analysis

April 9, 2009

Serentis starts phase II first-in-class SRD-441 study for eczema

April 8, 2009

Capstone initiates dosing in phase II AZX-100 pilot study in keloid scarring

April 7, 2009

PPD expands its compound partnering program into dermatology

April 7, 2009

Biotie initiates clinical trial with proprietary VAP-1 antibody in psoriasis

March 30, 2009

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 24, 2026.
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...
In the clinic for June 22, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Alkermes, Boehringer, Cambrian, F2G, Intrabio, Lexeo, Memo, Novocure,...